A Pilot Randomized Controlled Trial of Adding Enfuvirtide to Standard Combination Antiretroviral Therapy in HIV-Infected Individuals With Full Virologic Suppression to Further Suppress Proviral HIV DNA
Phase of Trial: Phase II
Latest Information Update: 04 Jun 2012
At a glance
- Drugs Enfuvirtide (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 04 Jun 2012 Actual end date (1 Jan 2010) added as reported by ClinicalTrials.gov.
- 04 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.